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Angucyclinones are a subclass of angucyclines, which are defined as
microbial quinone natural products related to tetracyclines and
anthracyclines and bearing, as characteristic structural feature, a
tetracyclic benz[a]anthracene ring system assembled in an angular
manner.1 This structural moiety is biosynthetically derived from a
decaketide chain formed via the polyketide biosynthetic pathway.
The term ‘angucycline’ includes molecules with hydrolysable sugar
moieties, whereas ‘angucyclinone’ refers to a sugarless compound or a
compound with a C-glycosidic linked sugar moiety.1,2 Angucyclines
are isolated from the fermentation broth of actinomycetes, mostly
from the genus Streptomyces, but also from Actinomadura, Nocardia
and Streptosporangium genera.1 Angucyclines show a broad spectrum
of biological activities including antitumor,1,2 antibacterial, antifungal,
antiviral,3,4 enzyme inhibitory5,6 and platelet aggregation inhibitory
properties.7,8 In a continuous search for new bioactive compounds
from actinomycetes other than the genus Streptomyces, several Saharan
soil samples collected in arid ecosystems were explored.9–11 Among
the isolates, we were interested by a new actinomycete strain belonging
to the genus Streptosporangium and producing a new compound (R2)
identified as a new angucyclinone. This paper describes the isolation,
structure elucidation and antimicrobial activities of compound R2.
Details on the isolation and the taxonomy of the producing
organism Streptosporangium sp. Sg3 were described in a previous
paper.11 To isolate compound R2, Streptosporangium sp. Sg3 was
cultivated at 30 1C for 9 days in Erlenmeyer flasks (500ml) containing
100ml of ISP2 broth (yeast extract 4 g, malt extract 10 g, glucose 4 g,
in 1 l distilled water, pH 7.2) on a rotary shaker (250 r.p.m.). The
cultures (8 l) were centrifuged and filtered to remove mycelium. The
culture filtrate was extracted with an equal volume of n-butanol to
generate a crude extract (1.9 g). The latter was fractionated by size
exclusion chromatography on Sephadex LH-20 (75%MeOH in H2O),
resulting in five fractions, I–V. Fraction IV including R2, was of
red color and exhibited an antibacterial activity. It was subjected
to semipreparative reversed-phase HPLC using an Interchim
UP5ODB column (2507.8mm) (Interchim, Montluc¸on, France)
and developed using a continuous grade from 20 to 75% MeOH in
H2O (UV detection at 220 nm), yielding three active fractions (1, 2, 3).
The major peak 2 with the main antibacterial activity was subjected to
repeated HPLC to yield 3.5mg of compound R2.
Compound R2 was obtained as a red powder (optical rotation
[a]D21 +56 (c 0.11, MeOH). The ESI-MS spectrum contained an ion
peak atm/z 475.1 [M–H], and its molecular formula was determined
by HRESI-MS analysis as C26H19O9 (calcd 475.43 for (M–H)
, found
475.43). The UV absorption maximum at 535 nm was because of the
red color and suggested a quinone chromophore. Absorptions at 3259,
2949 and 1721 cm1 in the IR spectrum of R2 were characteristic of
hydroxy, methyl and carbonyl groups, respectively. R2 was soluble in
MeOH and DMSO, and insoluble in chloroform, n-hexane and H2O.
The structure of R2 (Figure 1) was determined by 1H and 13C
NMR spectroscopy and by using 1H–1H COSY45, 1H–13C HMQC
and 1H–13C HMBC experiments. The 1H and 13C chemical shifts of
compound R2 are given in Table 1. The 13C and Heteronuclear Single-
Quantum Correlation spectra showed 26 carbon signals with a large
number of quaternary carbons (17 out of 26). From the 13C data, it
was possible to discern two keto-carbonyl groups (dc 188.4 and 186.5),
one carboxylic acid group (dc 174.1), 19 sp2-hybridized carbons (dc
from 160.2 to 114.7), two sp3-hybridized carbons bearing an electro-
negative heteroatom (dc 73.0 and 72.5), one sp3-hybridized carbon (dc
22.6) and two methyl groups (dc 22.4 and 12.4). In CD3OD, the 1H
NMR spectrum revealed two ortho-coupled aromatic protons (dH
7.82 and 7.66, 2H, J¼7.5Hz), two aromatic protons (dH 8.24 and
7.02, 2H, s), an AB system (dH 4.45 and 4.36, JAB¼10.7Hz), an ethyl
group (dH 2.83 and 1.32, 5H, J¼7.4Hz) and a methyl group (dH 2.70,
3H, s). In DMSO, NMR signals were significantly broader but the
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1H NMR spectrum showed additional resonances: four enol or
carboxylic acid protons (dH 17.64, 13.98, 13.20 and 13.08, 4H, s)
and two hydroxyl signals (dH 5.92 and 5.69, 2H, s). The 2D 1H–1H and
1H–13C experiments and especially the long range 1H–13C couplings
observed in the HMBC spectrum permitted to establish the presence of
a benzo[a]naphtacenequinone skeleton. Only four carbons did not
show any correlation in the HMBC spectrum (C1, C7a, C14 and C15).
Their assignment has been confirmed by comparison with NMR data
of the pradimicin antibiotic family.12 The peak of the four enol or
carboxylic acid protons was too broad to give HMBC correlations and
so could not be exactly assigned. The observed coupling constant of
10.7Hz between H5 and H6 suggested that the dihedral angles between
H5 and H6 are near 1801 and is consistent with a trans-diaxal
orientation. This value is similar with ones found for related com-
pounds3,12 where a 5S,6S absolute configuration has been deduced.
The structure of R2 was determined to be a benzo[a]naphtacene-
2-carboxylic acid,4,7,11,12-tetrahydro-1,5,6,9,14-pentahydroxy-8,13-
dioxo-3-methyl-10-ethyl.
The minimum inhibitory concentrations (MICs) of R2 were
determined by a conventional agar dilution method using nutrient
agar medium. Compound R2 showed strong activity against the
Gram-positive bacteria Micrococcus luteus ATCC 9314 and Bacillus
subtilis ATCC 6633 (MICs¼0.5 and 1mgml1, respectively), and
moderate activity against Staphylococcus aureus CIP 7625
(MIC¼10mgml1). A weak activity was observed against Listeria
monocytogenes CIP 82110 and Mycobacterium smegmatis ATCC 607
(MICs¼40 and 50mgml1, respectively). Compound R2 showed no
activity (MICs4100mgml1) against the Gram-negative bacteria
(Escherichia coli ATCC 10536 and Pseudomonas fluorescens number
412), the fungi (Mucor ramannianus NRRL 1829 and Aspergillus
carbonarius number M333) and the yeasts (Saccharomyces cerevisiae
ATCC 4226 and Candida albicans number 224).
In conclusion, from the results presented in this paper, we found
that strain Streptosporangium sp. Sg3 produces a new angucyclinone
that displayed antibacterial activities.
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Figure 1 Structure of angucyclinone R2 (a), and HMBC and COSY correlations (b).
Table 1 1H and 13C NMR data assignments of CD3OD at 298K
Position dC, mult. dH (J in Hz)
1 160.2, qCa —
2 118.5, qC —
3 143.1, qC —
4 116.9, CH 7.02,s
4a 147.4, qC —
5 72.5, CH 4.36, d (10.7)
6 73.0, CH 4.45, d (10.7)
6a 141.9, qC —
7 114.7, CH 8.24, s
7a 131.6, qC —
8 188.4, qC —
8a 115.2 qC —
9 160.1, qC —
10 139.9, qC —
11 135.3, CH 7.66, d (7.5)
12 118.7, CH 7.82, d (7.5)
12a 132.0, qC —
13 186.5, qC —
13a 117.4, qC —
14 158.6, qCa —
14a 128.6, qC —
14b 114.9, qC —
15 174.1, qC —
16 22.4, CH3 2.70, s
17 22.6, CH2 2.83, q (7.4)
18 12.4, CH3 1.32, t (7.4)
OH-1b,c — 17.64, s
OH-5c — 5.69, s
OH-6c — 5.92, s
OH-9b,c — 13.98, s
OH-14b,c — 13.08, s
COOHb,c — 13.20, s
a,bResonance assignment may be interchangeable.
cIn DMSO-d6.
Mult. stands for multiplicity. qC, CH, CH2 and CH3 indicate respectively quaternary, tertiary,
secondary and primary carbons.
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